CENX vs JAZZ · P/E 15, rev $2.53B vs P/E 1988, rev $2.28B
Century Aluminum Company (CENX) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
Century Aluminum Company (CENX) is a aluminum company listed on US.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported CENX revenue for 2025-12-31 was $2.53B. Net income was $41.8M. CENX currently screens at market cap $1.76B and trailing P/E 15.5.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
CENX currently screens at market cap $1.76B and trailing P/E 15.5. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the CENX and JAZZ stock pages for the full models.
Not investment advice.